Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor

A. Novotna, M. Korhonova, I. Bartonkova, AA. Soshilov, MS. Denison, K. Bogdanova, M. Kolar, P. Bednar, Z. Dvorak,

. 2014 ; 9 (7) : e101832.

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Azole antifungal ketoconazole (KET) was demonstrated to activate aryl hydrocarbon receptor (AhR). Since clinically used KET is a racemic mixture of two cis-enantiomers (2R,4S)-(+)-KET and (2S,4R)-(-)-KET, we examined the effects of KET enantiomers on AhR signaling pathway. (+)-KET dose-dependently activated AhR in human gene reporter cell line AZ-AHR, and displayed 5-20× higher agonist activity (efficacy), as compared to (-)-KET; both enantiomers were AhR antagonists with equal potency (IC50). Consistently, (+)-KET strongly induced CYP1A1 mRNA and protein in human HepG2 cells, while (-)-KET exerted less than 10% of (+)-KET activity. In primary human hepatocytes, both enantiomers preferentially induced CYP1A2 over CYP1A1 mRNA and protein, and the potency of (+)-KET was slightly higher as compared to (-)-KET. Ligand binding assay with guinea pig liver cytosols revealed that both (+)-KET and (-)-KET are weak ligands of AhR that displaced [3H]-TCDD with comparable potency. Similarly, both enantiomers weakly transformed AhR to DNA-binding form with similar potency, as showed by EMSA, in guinea pig liver cytosolic extracts and nuclear extracts from mouse Hepa-1 cells. We also examined effects of KET on glucocorticoid receptor (GR), a regulator of AhR activity. Both KET enantiomers antagonized GR with similar potency, as revealed by gene reporter assay in AZ-GR cell line and down-regulation of tyrosine aminotransferase mRNA in human hepatocytes. Finally, we demonstrate enantiospecific antifungal activities of KET enantiomers in six Candida spp. strains. In conclusion, the significance of current study is providing the first evidence of enatiospecific effects of cis-enantiomers of ketoconazole on AhR-CYP1A pathway.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014155
003      
CZ-PrNML
005      
20150421092124.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0101832 $2 doi
035    __
$a (PubMed)25000292
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Novotna, Aneta $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic.
245    10
$a Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor / $c A. Novotna, M. Korhonova, I. Bartonkova, AA. Soshilov, MS. Denison, K. Bogdanova, M. Kolar, P. Bednar, Z. Dvorak,
520    9_
$a Azole antifungal ketoconazole (KET) was demonstrated to activate aryl hydrocarbon receptor (AhR). Since clinically used KET is a racemic mixture of two cis-enantiomers (2R,4S)-(+)-KET and (2S,4R)-(-)-KET, we examined the effects of KET enantiomers on AhR signaling pathway. (+)-KET dose-dependently activated AhR in human gene reporter cell line AZ-AHR, and displayed 5-20× higher agonist activity (efficacy), as compared to (-)-KET; both enantiomers were AhR antagonists with equal potency (IC50). Consistently, (+)-KET strongly induced CYP1A1 mRNA and protein in human HepG2 cells, while (-)-KET exerted less than 10% of (+)-KET activity. In primary human hepatocytes, both enantiomers preferentially induced CYP1A2 over CYP1A1 mRNA and protein, and the potency of (+)-KET was slightly higher as compared to (-)-KET. Ligand binding assay with guinea pig liver cytosols revealed that both (+)-KET and (-)-KET are weak ligands of AhR that displaced [3H]-TCDD with comparable potency. Similarly, both enantiomers weakly transformed AhR to DNA-binding form with similar potency, as showed by EMSA, in guinea pig liver cytosolic extracts and nuclear extracts from mouse Hepa-1 cells. We also examined effects of KET on glucocorticoid receptor (GR), a regulator of AhR activity. Both KET enantiomers antagonized GR with similar potency, as revealed by gene reporter assay in AZ-GR cell line and down-regulation of tyrosine aminotransferase mRNA in human hepatocytes. Finally, we demonstrate enantiospecific antifungal activities of KET enantiomers in six Candida spp. strains. In conclusion, the significance of current study is providing the first evidence of enatiospecific effects of cis-enantiomers of ketoconazole on AhR-CYP1A pathway.
650    _2
$a senioři $7 D000368
650    _2
$a zvířata $7 D000818
650    _2
$a antifungální látky $x chemie $x farmakologie $7 D000935
650    _2
$a Candida $x účinky léků $7 D002175
650    _2
$a cytochrom P-450 CYP1A1 $x genetika $x metabolismus $7 D019363
650    _2
$a cytochrom P-450 CYP1A2 $x genetika $x metabolismus $7 D019388
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a morčata $7 D006168
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a hepatocyty $x účinky léků $x metabolismus $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a ketokonazol $x chemie $x farmakologie $7 D007654
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a lidé středního věku $7 D008875
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a receptory aromatických uhlovodíků $x metabolismus $7 D018336
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a stereoizomerie $7 D013237
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a genetická transkripce $x účinky léků $7 D014158
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Korhonova, Martina $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Bartonkova, Iveta $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Soshilov, Anatoly A $u Department of Environmental Toxicology, University of California Davis, Davis, California, United States of America.
700    1_
$a Denison, Michael S $u Department of Environmental Toxicology, University of California Davis, Davis, California, United States of America.
700    1_
$a Bogdanova, Katerina $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Kolar, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Bednar, Petr $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic.
700    1_
$a Dvorak, Zdenek $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Olomouc, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 7 (2014), s. e101832
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25000292 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150421092422 $b ABA008
999    __
$a ok $b bmc $g 1071736 $s 897033
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 7 $d e101832 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20150420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...